HPV-related oropharyngeal carcinoma de-escalation protocols

Affiliations

¹ Medical Oncology Department, Catalan Institute of Oncology, Badalona, Barcelona 08916, Spain; Medicine Department, University of Barcelona, Barcelona, Spain. Electronic address: rmesia@iconcologia.net.
² Medicine Department, University of Barcelona, Barcelona, Spain; Department of Medical Oncology and Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hopsitalet de Llobregat, Barcelona, Spain.

Comment

Ricard Mesía et al. Lancet Oncol. 2017 Jun.

. 2017 Jun;18(6):704-705.

doi: 10.1016/S1470-2045(17)30250-4. Epub 2017 Apr 20.

¹ Medical Oncology Department, Catalan Institute of Oncology, Badalona, Barcelona 08916, Spain; Medicine Department, University of Barcelona, Barcelona, Spain. Electronic address: rmesia@iconcologia.net.
² Medicine Department, University of Barcelona, Barcelona, Spain; Department of Medical Oncology and Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hopsitalet de Llobregat, Barcelona, Spain.

No abstract available

Comment on

Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
Chen AM, Felix C, Wang PC, Hsu S, Basehart V, Garst J, Beron P, Wong D, Rosove MH, Rao S, Melanson H, Kim E, Palmer D, Qi L, Kelly K, Steinberg ML, Kupelian PA, Daly ME. Chen AM, et al. Lancet Oncol. 2017 Jun;18(6):803-811. doi: 10.1016/S1470-2045(17)30246-2. Epub 2017 Apr 20. Lancet Oncol. 2017. PMID: 28434660 Free PMC article. Clinical Trial.